Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.

 
Web www.patentalert.com

< Universal readout for target identification using biological microarrays

< Compositions and methods for identifying antigens which elicit an immune response

> Isolated recombinant vaccinia virus complement control protein (hrVCP) polypeptide

> Aminoglycoside treatment for lysosomal storage diseases
~ 00620